Diligence memo · auto-generated · as of July 2, 2026
Aidia Investment Group, Inc.
Aidia Investment Group, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Aidia Investment Group, Inc. operates in Biotechnology, based in RESEARCH TRIANGLE PARK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Aidia Investment Group, Inc. has raised $500K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $500K on 2017-12-11.
Most recent recorded round closed around 2017-12-11.
Valuation (modeled)modeled
Provath models Aidia Investment Group, Inc. at approximately $28M (range $267K–$313M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.31× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era. Within the normal band (131% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 8.6 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 11% of Biotechnology peers (4293 compared).
Modeled value ranks above 34% of those peers.
Closest niche peers: New Vital Signs, Inc., Cerebral Magnetics INC, NutriBand Inc., Jivana Biotechnology Inc, AnTolRx, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.